Post by
Gary1959 on Feb 04, 2016 11:09am
This company has a product .going for phase 3 trials again.
The fact that the FDA wants another study tell me they know theres something there worth a second look. I see this as totally positive. And an amazing buying opportunity.
Comment by
iperform4u on Feb 04, 2016 11:12am
I agree, this a buying opportunity at current SP
Comment by
vega509 on Feb 04, 2016 11:14am
the question remains, where is the money going to come from to keep the company afloat, and pay the cost of another trial, which could take several years? anyone notice Ipsen has been quiet?
Comment by
ragingbull1234 on Feb 04, 2016 11:43am
My guess is that the money is going to come from ENDO and they will take the ball and run with it.